icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
National Estimates for HCV Screening and Diagnosis Rates in the United States (2013-2016) Based on a Large Real-World Dataset
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
 
Mark S. Sulkowski1, Steve E. Marx2, Shivaji R. Manthena2, John P. Strezewski2 and Viktor V. Chirikov3 1Johns Hopkins Hospital, Baltimore, MD, USA, 2Abbvie Inc ., North Chicago, IL, USA, 3Pharmerit International, LP, Bethesda, MD, USA
 
Poster pdf attached
 
Download the PDF Here
 
from Jules: CDC Recommends one-time universal HCV screening for all baby boomers, yet look at the low screening for all here, both baby boomers & young adults. Ab screening rates are the highest (see Table below) in DC, MD, FL, NY, Nevada, but are very low considering Universal screening for baby boomers is recommended by CDC.
 

HCV

[from Jules: This speaks to the notion that HCV among young IDUs prevalence outnumbers among older bay boomers, its a false notion, but trend are changing regarding incidence.]
 
"The number of persons with detected active infection (RNA+ post AB+ test) increased from 28,139 in 2013 to 67,223 in 2016 for baby boomers and from 10,794 to 42,263 for young adults. 525,426 patients had HCV RNA+ test and no previous HCV AB test over 2013-2016."
 
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
 
Mark S. Sulkowski1, Steve E. Marx2, Shivaji R. Manthena2, John P. Strezewski2 and Viktor V. Chirikov3 1Johns Hopkins Hospital, Baltimore, MD, USA, 2Abbvie Inc ., North Chicago, IL, USA, 3Pharmerit International, LP, Bethesda, MD, USA

1112182

1112183

1112184

1112185

1112186

1112187

1112188

1112189